Using laser capture microdissection followed by label-free quantitative mass spectrometry of CP, signaling pathways in activated fatty acid beta-oxidation and inhibited glycolysis were changed in patients with AD compared with controls [86]. This evidence concerns the gene CP and Alzheimer disease.